Ozempic label now notes potential side effect of intestinal blockage
- The FDA has updated the label of the diabetes drug Ozempic to acknowledge reports of blocked intestines, while also acknowledging reports of a similar condition for its sister drug Wegovy.
- Ozempic and Wegovy have seen a surge in popularity and are known to cause gastrointestinal side effects such as delayed gastric emptying, nausea, and vomiting.
- A lawsuit has been filed against Novo Nordisk and Eli Lilly by a woman who claims severe gastrointestinal events and resulting injury from using Ozempic and Mounjaro.
Insights by Ground AI
Does this summary seem wrong?
37 Articles
37 Articles
All
Left
4
Center
30
Right
Coverage Details
Total News Sources37
Leaning Left4Leaning Right0Center30Last UpdatedBias Distribution88% Center
Bias Distribution
- 88% of the sources are Center
88% Center
12%
C 88%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage